PD123319

Catalog No.S7098

PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.

Price Stock Quantity  
USD 147 In stock
USD 470 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

PD123319 Chemical Structure

PD123319 Chemical Structure
Molecular Weight: 508.61

Validation & Quality Control

Quality Control & MSDS

Product Information

  • Compare RAAS Inhibitors
    Compare RAAS Products
  • Research Area

Product Description

Biological Activity

Description PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.
Targets AT2 receptor [1]
IC50 34 nM
In vitro PD 123319 is shown to discriminate between two subclasses of AII receptors in many different tissues. 125I-AII specifically labeled two classes of binding sites for AII in a membrane preparation of bovine adrenal glomerulosa cells. The first class (DuP-753 sensitive) represents approximately 85% of the total binding sites for AII and possesses a high affinity (IC50 of 92.9 nM) for DuP-753. PD-123319 does not have any effect on 125I-AII binding to this site. The second class of binding sites is more sensitive to PD-123319, with an IC50 of 6.9 nM, and has a much lower affinity for DuP-753 (IC50 around 10 microM). [2]
In vivo PD 123319 has no effect on cerebral blood flow autoregulation. Acute AT2-receptor blockade does not influence CBF autoregulation. [3]Intravenous administration of PD 123319 to conscious hypertensive rats elicites an immediate dose-dependent increase in MAP that is sustained for approximately 7.4 min with 3 mg/kg PD 123319. [4]
Features

Protocol(Only for Reference)

Animal Study: [3]

Animal Models spontaneously hypertensive rats
Formulation saline
Dosages 0.36 and 1 mg/kg/min
Administration intravenous

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Blankley CJ, et al. J Med Chem, 1991, 34(11), 3248-3260.

[2] Boulay G, et al. Mol Pharmacol, 1992, 41(4), 809-815.

view more

Chemical Information

Download PD123319 SDF
Molecular Weight (MW) 508.61
Formula

C31H32N4O3

CAS No. 130663-39-7
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 100 mg/mL (196.61 mM)
Water 100 mg/mL (196.61 mM)
Ethanol 100 mg/mL (196.61 mM)
In vivo Saline 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 1H-Imidazo[4,5-c]pyridine-6-carboxylic acid, 1-[[4-(dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-, (6S)-

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related RAAS Products

  • LCZ696

    LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.

  • Endoxifen HCl

    Endoxifen HCl, the active metabolite of Tamoxifen, ia a potent and selective estrogen receptor antagonist. Phase 2.

  • Licochalcone A

    Licochalcone A is an estrogenic flavanoid extracted from licorice root, showing antimalarial, anticancer, antibacterial and antiviral activities. Phase 3.

  • Losartan Potassium (DuP 753)

    Losartan is an angiotensin II receptor antagonist, competes with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.

    Features:Losartan has a major active metabolite, EXP 3174.

  • Aliskiren Hemifumarate

    Aliskiren hemifumarate is a direct renin inhibitor with IC50 of 1.5 nM.

  • Telmisartan

    Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension.

  • Azilsartan Medoxomil

    Azilsartan Medoxomil is a potent angiotensin II type 1 (AT1) receptor antagonist, inhibits the RAAS, with an IC50 of 2.6 nM, exhibits >10,000-fold selectivity over AT2.

  • Candesartan

    Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM.

    Features:Primarily used for the treatment of hypertension.

  • Perindopril Erbumine

    Perindopril Erbumine is a potent ACE inhibitor with IC50 of 1.05 nM.

  • Enalaprilat Dihydrate

    Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 1.94 nM.

    Features:The 1st dicarboxylate-containing ACE inhibitor developed to overcome captopril limitations.

Recently Viewed Items

Tags: buy PD123319 | PD123319 supplier | purchase PD123319 | PD123319 cost | PD123319 manufacturer | order PD123319 | PD123319 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us